Results from evaluations of models and cost-effectiveness tools to support introduction decisions for new vaccines need critical appraisal.
about
Modeling cholera outbreaksHealth and economic outcomes of introducing the new MenB vaccine (Bexsero) into the Italian routine infant immunisation programmeEnhancing the work of the Department of Health and Human Services national vaccine program in global immunization: recommendations of the National Vaccine Advisory Committee: approved by the National Vaccine Advisory Committee on September 12, 2013Comparative review of three cost-effectiveness models for rotavirus vaccines in national immunization programs; a generic approach applied to various regions in the world.Economic analyses to support decisions about HPV vaccination in low- and middle-income countries: a consensus report and guide for analystsEvaluation of targeted mass cholera vaccination strategies in Bangladesh: a demonstration of a new cost-effectiveness calculator.Systematic review of the cost-effectiveness of the vaccination against HPV in Brazil.Decision-making on malaria vaccine introduction: the role of cost-effectiveness analyses.The use of cost-effectiveness analysis for pediatric immunization in developing countriesPublic health impact and cost-effectiveness of the RTS,S/AS01 malaria vaccine: a systematic comparison of predictions from four mathematical modelsMethods for Health Economic Evaluation of Vaccines and Immunization Decision Frameworks: A Consensus Framework from a European Vaccine Economics CommunityCurrent issues in the economics of vaccination against dengue.Dynamic transmission modeling: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force Working Group-5.Cost-effectiveness analysis of introducing universal childhood rotavirus vaccination in Bangladesh.
P2860
Q27006979-3FC42DA5-3999-439D-B40D-CD66D470F8F4Q28391723-D9AD20F8-ED63-4563-8A46-751DB19BB2FFQ28654939-C3CCBD61-A05C-466D-A0ED-444D71FBB2F1Q33955841-58E208DF-745C-4935-B10C-AFF67C48FA8AQ34567701-77962098-788F-487C-A89F-4191C1BBFDFBQ34640244-D98BB86A-BE86-4C9A-9735-B40C82FC092AQ35886544-63D40E7C-1032-4911-B050-ED590402E71BQ36423357-2F3A5BF0-47D2-4F0E-B3E2-CF93DF89C247Q36490234-AB350B2D-214D-499A-A3EB-786924C1822DQ36492529-3E13D980-18E5-409E-BC37-0789D851CFA6Q36615123-E1D4588B-5463-42D7-8698-618D14D8A54AQ38661075-C054FABB-BC68-4F21-8A92-B14BAA56877DQ39550770-C808C0B6-7AC0-4786-AD2A-6F510F0A5FA7Q47861443-642714F6-4F73-4CBA-829A-0144A177BDF4
P2860
Results from evaluations of models and cost-effectiveness tools to support introduction decisions for new vaccines need critical appraisal.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Results from evaluations of mo ...... cines need critical appraisal.
@ast
Results from evaluations of mo ...... cines need critical appraisal.
@en
type
label
Results from evaluations of mo ...... cines need critical appraisal.
@ast
Results from evaluations of mo ...... cines need critical appraisal.
@en
prefLabel
Results from evaluations of mo ...... cines need critical appraisal.
@ast
Results from evaluations of mo ...... cines need critical appraisal.
@en
P2093
P2860
P356
P1433
P1476
Results from evaluations of mo ...... cines need critical appraisal.
@en
P2093
Ana Maria Henao
Joachim Hombach
Pem Namgyal
Raymond Hutubessy
Vasee Moorthy
P2860
P2888
P356
10.1186/1741-7015-9-55
P407
P577
2011-05-12T00:00:00Z
P5875
P6179
1020566756